Leishmaniasis is a neglected tropical disease caused by Leishmania parasitic protozoa, which currently lacks efficient treatment. Natural products have shown promise as a potential source for antiprotozoal drugs. This work focuses on the antileishmanial potential of Sassafras albidum (Lauraceae) bark extract. The crude bark extract of S. albidum showed excellent antileishmanial activity with an IC 50 value less than 12.5 μg/mL against promastigotes of L. amazonensis. The chloroform stem bark extract of S. albidum was subjected to preparative column chromatography. Five compounds were isolated, purified by recrystallization, and identified as sesamin, spinescin, β-sitosterol, hexatriacontanal, and 1-triacontanol. Antileishmanial and cytotoxic screening were performed on these compounds. Sesamin exhibited the best activity against L. amazonensis with an IC 50 of 15.8 μg/mL and was not cytotoxic to mouse macrophage cells (CC 50 > 100 μg/mL).
Leishmaniasis is an infection caused by protozoan parasites belonging to the genus Leishmania (Trypanosomitidae) and is spread to people through the bite of female phlebotomine sandflies. It is an important neglected tropical disease affecting children more than adults. It is mostly concentrated in poor countries, and is endemic in several continents except Australia, affecting millions of people. The disease is manifested in three main clinical forms, which include the most common (a) cutaneous leishmaniasis that affects the skin, (b) mucocutaneous leishmaniasis affecting the oronasal and pharyngeal cavities, and the most fatal form (c) visceral leishmaniasis that affects the vital organs [1]. The current treatment options for leishmaniasis include pentavalent antimonials, pentamidine, and amphotericin B, but all these drugs have severe drawbacks, including drug resistance, side effects, difficulty in administration, and prohibitive cost [2] . Hence, there has been an increase in efforts by researchers to discover alternative drugs and efficient therapeutic options. Much recent research has focused on natural products as sources for antileishmanial treatment options [3] .
Sassafras albidum (Nutt.) Nees (Lauraceae) is a medium-sized deciduous tree that ranges from central Florida, north to New England and the Great Lakes, and west to eastern Texas and Oklahoma [4] . Several studies have focused on S. albidum essential oil compositions and uses [5] . The chief constituent of the root oil is safrole (80%). The root oil is used to make traditional sassafras tea which is used medicinally as a sudorific, flavoring agent, stimulant, carminative, and diaphoretic. However, its use has been discontinued due to the carcinogenicity of safrole [6] . Apart from this, S. albidum leaf oil is dominated by geranial and neral [5] ; the bark essential oil, rich in α-pinene, β-pinene, and 1,8-cineole, has shown allelopathic influences [7] and these are believed to be responsible for the negative host association of poison ivy [8] . S. albidum crude bark extract had demonstrated excellent in vitro leishmanicidal activity against L. amazonensis promastigotes and amastigotes without cytotoxicity to BALB/c mouse macrophages [9] . In this paper, we report the antileishmanial activity of compounds isolated from the chloroform bark extract of S. albidum. S. albidum bark, collected in Huntsville, Alabama, was extracted with chloroform, and the crude extract subjected to preparative flash chromatography on silica gel. Five compounds were isolated and purified by recrystallization: hexatriacontanal, 1-triacontanol, βsitosterol, sesamin, and spinescin. The compounds were screened for antileishmanial activity against L. amazonensis promastigotes (Table 1) . β-Sitosterol, sesamin, and spinescin had been previously isolated from S. albidum root bark extract [10] . Based on this study, the lignan sesamin looks to be a promising candidate for further antileishmanial investigation with excellent leishmanicidal activity and no cytotoxic activity to mouse macrophage cells. This compound had previously demonstrated antiparasitic activity against Plasmodium falciparum [11] and Trypanosoma brucei [12] , but is apparently inactive against T. cruzi [13] , Leishmania chagasi [14] , and L. donovani [15] . Molecular docking studies have suggested that Leishmania pteridine reductase or glycerol-3-phosphate dehydrogenase may be biochemical targets of sesamin [16] .
